Abdulafeez Katibi Abdulkadir
Research Subjects
Research Interests
Abdulafeez Katibi Abdulkadir has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Enyinnaya Ukaegbu
Department of Biomedical Sciences, School of Medicine, Nazarbayev University, Astana, Kazakhstan
2 shared publications - Usman Abubakar Haruna
Ahmadu Bello University, Zaria, Nigeria
2 shared publications - Abduzhappar Gaipov
Department of Medicine, School of Medicine, Nazarbayev University, Astana, Kazakhstan
1 shared publication - Adamu Muhammad Ibrahim
Department of Immunology, School of Medical Laboratory Science, Usmanu Danfodiyo University, Sokoto, Nigeria
1 shared publication - Ahmed Adamu Gololo
Department of Social and Administrative Pharmacy, Faculty of Pharmaceutical Sciences Chulalongkorn University Bangkok Thailand
1 shared publication - Ainash Oshibayeva
Faculty of Medicine, Khoja Akhmet Yassawi International Kazakh-Turkish University, Turkestan 160000, Kazakhstan
1 shared publication
Latest Publications
- 19 November 2025
- Published by Modestum Ltd in Electronic Journal of General Medicine
- Vol. 22 (6) , em702
Analysis of epidemiological characteristics of leukemia in Kazakhstan using unified nationwide electronic healthcare data
Background: Leukemia is the fifth leading cause of cancer mortality worldwide. Based on the rate of cellular division, leukemia is classified into acute or chronic myeloid or lymphoid types. Previous studies have highlighted rising leukemia cases in Kazakhstan; however, no study has described the epidemiology of leukemia and its subtypes. Methods: This retrospective cohort study uses the unified nationwide electronic healthcare system to characterize the epidemiology of leukemia and its subtypes in patients treated in any clinical setting in Kazakhstan from 2014 to 2019. The Chi-square test was used for categorical variables, the independent t-tests for continuous numeric variables between two groups, and ANOVA for comparing means across multiple groups. A cox proportional hazards regression model calculates crude and adjusted hazard ratios for all-cause mortality risk. Results: Of 9,561 patients, 4,783 (50.1%) were male and 4,778 (49.9%) were female. Median survival was 12 years (4,508 days). Mortality rates varied, with a slight increase in unspecified leukemia (C95) diagnoses in 2018-2019. Males (HR = 1.15, [95% CI: 1.07-1.23]), urban residents (HR = 1.52, [95% CI: 1.40-1.65]), and older individuals had higher mortality risks. Russians (HR = 1.42, [95% CI: 1.28-1.57]) and patients with hypertension (HR = 1.58, [95% CI: 1.53-1.64]) or chronic kidney disease (HR = 1.84, [95% CI: 1.60-2.10]) faced higher risk of death. Conclusion: Leukemia incidence and mortality in Kazakhstan are higher among males, urban residents, older individuals, and patients with comorbidities. These findings highlight the need for targeted healthcare policies and clinical management strategies to address disparities and improve outcomes in Kazakhstan.
- 19 November 2025
- Published by Modestum Ltd in Electronic Journal of General Medicine
- Vol. 22 (6) , em702
Analysis of epidemiological characteristics of leukemia in Kazakhstan using unified nationwide electronic healthcare data
Background: Leukemia is the fifth leading cause of cancer mortality worldwide. Based on the rate of cellular division, leukemia is classified into acute or chronic myeloid or lymphoid types. Previous studies have highlighted rising leukemia cases in Kazakhstan; however, no study has described the epidemiology of leukemia and its subtypes. Methods: This retrospective cohort study uses the unified nationwide electronic healthcare system to characterize the epidemiology of leukemia and its subtypes in patients treated in any clinical setting in Kazakhstan from 2014 to 2019. The Chi-square test was used for categorical variables, the independent t-tests for continuous numeric variables between two groups, and ANOVA for comparing means across multiple groups. A cox proportional hazards regression model calculates crude and adjusted hazard ratios for all-cause mortality risk. Results: Of 9,561 patients, 4,783 (50.1%) were male and 4,778 (49.9%) were female. Median survival was 12 years (4,508 days). Mortality rates varied, with a slight increase in unspecified leukemia (C95) diagnoses in 2018-2019. Males (HR = 1.15, [95% CI: 1.07-1.23]), urban residents (HR = 1.52, [95% CI: 1.40-1.65]), and older individuals had higher mortality risks. Russians (HR = 1.42, [95% CI: 1.28-1.57]) and patients with hypertension (HR = 1.58, [95% CI: 1.53-1.64]) or chronic kidney disease (HR = 1.84, [95% CI: 1.60-2.10]) faced higher risk of death. Conclusion: Leukemia incidence and mortality in Kazakhstan are higher among males, urban residents, older individuals, and patients with comorbidities. These findings highlight the need for targeted healthcare policies and clinical management strategies to address disparities and improve outcomes in Kazakhstan.
- Open Access
- 31 December 2024
- Published by Narra Sains Indonesia in Narra X
- Vol. 2 (3) , e178
Revitalizing the state of primary healthcare towards achieving universal health coverage in conflict affected fragile northeastern Nigeria: Challenges, strategies and way forward
The Alma-Ata Declaration of 1978 defined primary healthcare as a critical way to obtain universal health care and 'health for all.' In Nigeria, the National Health Policy (NHP) and the subsequent formation of the Primary Health Care (PHC) system aim to modernize healthcare delivery, at the grassroots level. In recent decades, however, the status of primary healthcare in Nigeria, particularly in the northeastern region, has significantly deteriorated, further posing significant threats to health equity and universal access to healthcare. Armed conflicts, humanitarian crises, insufficient finance, inadequate infrastructure, and labor shortages have negatively impacted the region's PHC facilities. This article discusses the poor state of primary healthcare in northeastern Nigeria and its implications for achieving universal health coverage in the region. In addition, the article elaborates on the historical context, highlights the difficulties and challenges in the development of primary healthcare, and explores potential solutions to improve the system.
- 31 December 2024
- Published by Narra Sains Indonesia in Narra X
- Vol. 2 (3) , e178
Open AccessRevitalizing the state of primary healthcare towards achieving universal health coverage in conflict affected fragile northeastern Nigeria: Challenges, strategies and way forward
The Alma-Ata Declaration of 1978 defined primary healthcare as a critical way to obtain universal health care and 'health for all.' In Nigeria, the National Health Policy (NHP) and the subsequent formation of the Primary Health Care (PHC) system aim to modernize healthcare delivery, at the grassroots level. In recent decades, however, the status of primary healthcare in Nigeria, particularly in the northeastern region, has significantly deteriorated, further posing significant threats to health equity and universal access to healthcare. Armed conflicts, humanitarian crises, insufficient finance, inadequate infrastructure, and labor shortages have negatively impacted the region's PHC facilities. This article discusses the poor state of primary healthcare in northeastern Nigeria and its implications for achieving universal health coverage in the region. In addition, the article elaborates on the historical context, highlights the difficulties and challenges in the development of primary healthcare, and explores potential solutions to improve the system.